What are the recommended treatments for pain control in rheumatoid arthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pain Management in Rheumatoid Arthritis

The most effective approach to pain control in rheumatoid arthritis requires a combination of disease-modifying antirheumatic drugs (DMARDs) as the foundation, with NSAIDs and other analgesic interventions as adjunctive treatments tailored to the patient's specific pain mechanisms and disease activity.

Understanding Pain in Rheumatoid Arthritis

Pain in rheumatoid arthritis (RA) is multifactorial, arising from:

  • Active inflammation in joints
  • Secondary osteoarthritis
  • Central and peripheral pain sensitization
  • Structural joint damage

First-Line Treatment: Disease Control

DMARDs (Disease-Modifying Antirheumatic Drugs)

  • Methotrexate is the anchor drug and should be used first in patients at risk of developing persistent disease 1
  • DMARDs should be started as early as possible, ideally within 3 months of symptom onset 1
  • The main goal of DMARD treatment is to achieve remission, which will significantly reduce inflammatory pain 1

Adjunctive Pain Management Options

1. NSAIDs

  • Should be considered in symptomatic patients after evaluation of gastrointestinal, renal, and cardiovascular status 1
  • Use at minimum effective dose for shortest time possible 1
  • Options include:
    • Ibuprofen (possesses analgesic and antipyretic activities) 2
    • Naproxen (shown effective in controlled trials) 3
    • COX-2 inhibitors (may have fewer GI side effects)

2. Glucocorticoids

  • Reduce pain and swelling effectively and should be considered as adjunctive treatment 1
  • Should be used temporarily as part of DMARD strategy 1
  • For prolonged treatment, dosage should be kept to minimum 1
  • Administration options:
    • Systemic (oral, IV)
    • Intra-articular injections for relief of local symptoms of inflammation 1

3. Biologic DMARDs

  • Consider when conventional DMARDs provide inadequate response 4
  • Anti-TNF agents (adalimumab, etanercept, infliximab) 5
  • Other biologics (abatacept, tocilizumab, rituximab) 4

4. Non-Pharmacological Interventions

  • Physical activity and exercise interventions show most uniformly positive effects on pain 1
  • Types of beneficial exercise:
    • Aerobic exercise
    • Strength and resistance training
    • Aquatic exercise
    • Mind-body exercise 1
  • Psychological interventions have demonstrated positive effects on pain 1
  • Occupational therapy 1
  • Weight management (for those who are overweight) 1

Pain Management Algorithm

  1. Assess disease activity and pain characteristics:

    • Determine if pain is primarily inflammatory or non-inflammatory
    • Evaluate joint swelling, tenderness, morning stiffness
    • Use validated disease activity measures
  2. Optimize DMARD therapy first:

    • Methotrexate as anchor drug
    • Add or switch DMARDs if inadequate response
    • Consider biologics for refractory disease
  3. Add adjunctive pain treatments:

    • For inflammatory pain: NSAIDs and/or short-term glucocorticoids
    • For localized joint pain: Consider intra-articular glucocorticoid injections
    • For persistent pain despite controlled inflammation: Consider central pain mechanisms
  4. Implement non-pharmacological approaches:

    • Prescribe appropriate exercise program
    • Consider psychological interventions for pain coping
    • Address sleep disturbances that may amplify pain 1

Important Considerations and Pitfalls

  • Avoid focusing only on pain without addressing underlying inflammation - disease control is paramount
  • Be cautious with long-term NSAID use due to potential cardiovascular, renal, and gastrointestinal risks 1
  • Recognize that pain may persist despite well-controlled inflammation due to central sensitization 1
  • Differentiate inflammatory from non-inflammatory pain sources to guide appropriate treatment 1
  • Regular monitoring of disease activity and treatment response is essential 1
  • Avoid long-term glucocorticoid use when possible due to cumulative side effects 1

By implementing this comprehensive approach to pain management in RA that addresses both the underlying disease process and pain mechanisms, most patients can achieve significant pain relief and improved quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Naproxen in rheumatoid arthritis. A controlled trial.

Annals of internal medicine, 1975

Research

Pharmacotherapy options in rheumatoid arthritis.

Clinical medicine insights. Arthritis and musculoskeletal disorders, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.